5 studies found for:    PTC299
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Suspended PTC299 for Treatment of Neurofibromatosis Type 2
Condition: Neurofibromatosis 2
Intervention: Drug: PTC299
2 Suspended PTC299 for Treatment of Advanced Cancer
Condition: Advanced Cancer
Intervention: Drug: PTC299
3 Terminated
Has Results
PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma
Condition: Kaposi's Sarcoma
Interventions: Drug: VEGF inhibitor PTC299;   Genetic: gene expression analysis;   Genetic: polymerase chain reaction;   Genetic: protein expression analysis;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Procedure: biopsy
4 Completed PTC299 and Hormonal Agent for Treatment of Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Intervention: Drug: PTC299
5 Suspended PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors
Condition: Brain and Central Nervous System Tumors
Intervention: Drug: VEGF inhibitor PTC299

Indicates status has not been verified in more than two years